Inhalerx Ltd IRX:ASX

*Data is delayed | AUD
Last | 09/29/22 AET
0.069UNCH (UNCH)
52 week range
0.05 - 0.13
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.069
  • 52 Week High0.13
  • 52 Week High Date04/13/22
  • 52 Week Low0.05
  • 52 Week Low Date09/14/22

Key Stats

  • Market Cap6.84M
  • Shares Out168.47M
  • 10 Day Average Volume293,456.67
  • Dividend-
  • Dividend Yield-
  • Beta-1.13
  • YTD % Change-23.33

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.069
  • 52 Week High0.13
  • 52 Week High Date04/13/22
  • 52 Week Low0.05
  • 52 Week Low Date09/14/22
  • Market Cap6.84M
  • Shares Out168.47M
  • 10 Day Average Volume293,456.67
  • Dividend-
  • Dividend Yield-
  • Beta-1.13
  • YTD % Change-23.33

RATIOS/PROFITABILITY

  • EPS (TTM)-0.01
  • P/E (TTM)-7.84
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Inhalerx Ltd

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Inhalerx Ltd. is an Australia-based medical technology company. The Company is focused on developing inhaled therapies and medicine delivery systems. The Company partners with educators in their technical and therapeutic fields, to provide inhalation therapies that deliver added value for patients, doctors, business partners, governments, and stakeholders alike. The Company's Medihale Inhaler is a sealed pod inhaler designed specifically for use with inhaled formulations. It...
Sean Williams
Non-Executive Chairman of the Board
Darryl Davies
Chief Executive Officer
Address
Suite 103 Level 1, 2 Queen Street
Melbourne, VIC
3000
Australia